Surfacide, a leader in UV-C light technology, has announced the launch of its GLŌ PX Program.
“Knowing there is a strong correlation between patient satisfaction and (perceived) cleanliness, the GLŌ PX Program focuses on the intersection between the two, aiding in the improvement of a hospital’s HCAHPS scores, according to a press release. This in turn can help the hospital’s bottom line, because as the Harvard Business Review reported, “A 5-point increase in overall hospital rating (based on HCAHPs), leads to, on average, a 1% to 2% increase in profit margin.”
“GLŌ PX is led by a team of Surfacide experts that design tailored programs for each organization they partner with. The monthly subscription allows hospitals the ability to use Surfacide’s award-winning Helios ‘robotic’ UV-C light solution to reduce bioburden, without having to wait on the capital budget process. Additionally, the facility receives custom scripting, training and data analytics reports,” the release states.
“As we know, a hospital’s brand and reputation play a significant role in acquiring new patients and inspiring loyalty, which leads to improved financial outcomes,” said Gunner Lyso, founder and CEO of Surfacide. “With the GLŌ PX Program not only do patients have a front-row seat to Sufacide’s UV-C technology, but they also receive a personalized conversation from the hospital’s certified GLŌ Patient Ambassador, transcending the typical bedside experience into a memorable one, bolstering the patient’s trust in the hospital.”
Increasing a health care facility’s overall performance is directly linked to employee motivation and engagement. Surfacide recognizes that implementing a program like GLŌ PX allows employees to work and participate in a modern, inventive health care environment, resulting in job satisfaction and employee retention.
“Since adopting the Surfacide UV-C technology and the GLŌ PX program on campus, our patient satisfaction scores continue to significantly improve,” said Joseph Alcure, EVS manager at Holy Cross Hospital, Fort Lauderdale.
